Patents by Inventor Steven Burakoff

Steven Burakoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF HPK1
    Publication number: 20230022524
    Abstract: Disclosed are Hematopoietic Progenitor Kinase 1 (HPK1) degradation/disruption compounds including a HPK1 ligand, a degradation/disruption tag and a linker, and methods for use of such compounds in the treatment of HPK1-mediated diseases.
    Type: Application
    Filed: May 5, 2020
    Publication date: January 26, 2023
    Inventors: Jian Jin, Steven Burakoff, H. Umit Kaniskan, Sansana Sawasdikosol, He Chen, Joshua Brody, Nina Bhardwaj
  • Hematopoietic progenitor kinase 1 for modulation of an immune response
    Publication number: 20070087988
    Abstract: Methods of regulating hematopoietic progenitor kinase 1 (HPK1) are described as are methods of identifying compounds that can regulate HPK1.
    Type: Application
    Filed: October 2, 2006
    Publication date: April 19, 2007
    Applicant: New York University
    Inventors: Sansana Sawasdikosol, Saba Alzabin, Steven Burakoff
  • Terminally blocked antiviral peptides
    Patent number: 5447915
    Abstract: This invention relates to antiviral peptide compounds and to methods of inhibiting infection of human cells by viruses. This invention pertains more specifically to peptides that are chemically blocked at the amino- and carboxy-termini. In particular the invention relates to peptides comprised of prolylalanine or prolylphenylalanine compounds that have antiviral activity. The invention is specifically directed to methods for preventing infection of human cells in vivo and in vitro with the human immunodeficiency virus HIV-1 and methods for treating human infected with this and other viruses. The invention also relates to the diagnostic and therapeutic use of these antiviral peptide compounds.
    Type: Grant
    Filed: August 28, 1992
    Date of Patent: September 5, 1995
    Assignees: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Stuart Schreiber, Steven Burakoff